EGFR and melanoma: Since melanoma cells lacking EGFR expression are sensitive to vemurafenib due to the absence of this feedback activation, and since the ectopic expression of EGFR causes resistance to vemurafenib in melanoma cells, the upregulation of EGFR is a prerequisite for the development of this mechanism of drug resistance [17].